UY27678A1 - Sal agonista del receptor b3 andrenérgico, sus formulaciones y usos. - Google Patents
Sal agonista del receptor b3 andrenérgico, sus formulaciones y usos.Info
- Publication number
- UY27678A1 UY27678A1 UY27678A UY27678A UY27678A1 UY 27678 A1 UY27678 A1 UY 27678A1 UY 27678 A UY27678 A UY 27678A UY 27678 A UY27678 A UY 27678A UY 27678 A1 UY27678 A1 UY 27678A1
- Authority
- UY
- Uruguay
- Prior art keywords
- salt
- monohydrate
- pharmaceutical compositions
- andrenérgico
- formulations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Obesity (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36024802P | 2002-02-27 | 2002-02-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY27678A1 true UY27678A1 (es) | 2003-10-31 |
Family
ID=27766205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY27678A UY27678A1 (es) | 2002-02-27 | 2003-02-25 | Sal agonista del receptor b3 andrenérgico, sus formulaciones y usos. |
Country Status (8)
| Country | Link |
|---|---|
| AR (1) | AR038603A1 (fr) |
| AU (1) | AU2003248355A1 (fr) |
| GT (1) | GT200300044A (fr) |
| PA (1) | PA8567601A1 (fr) |
| PE (1) | PE20030900A1 (fr) |
| TW (1) | TW200305414A (fr) |
| UY (1) | UY27678A1 (fr) |
| WO (1) | WO2003072571A1 (fr) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9812709D0 (en) * | 1998-06-13 | 1998-08-12 | Glaxo Group Ltd | Chemical compounds |
| CA2423792A1 (fr) * | 2000-10-20 | 2002-04-25 | Pfizer Products Inc. | Ethanolamines alpha-aryle et utilisation de ces dernieres en tant qu'agonistes du recepteur adrenergique beta-3 |
-
2003
- 2003-02-17 AU AU2003248355A patent/AU2003248355A1/en not_active Abandoned
- 2003-02-17 WO PCT/IB2003/000575 patent/WO2003072571A1/fr not_active Application Discontinuation
- 2003-02-24 PE PE2003000179A patent/PE20030900A1/es not_active Application Discontinuation
- 2003-02-25 UY UY27678A patent/UY27678A1/es not_active Application Discontinuation
- 2003-02-25 AR ARP030100606A patent/AR038603A1/es not_active Application Discontinuation
- 2003-02-26 TW TW092104035A patent/TW200305414A/zh unknown
- 2003-02-26 GT GT200300044A patent/GT200300044A/es unknown
- 2003-02-26 PA PA20038567601A patent/PA8567601A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR038603A1 (es) | 2005-01-19 |
| PA8567601A1 (es) | 2003-12-10 |
| PE20030900A1 (es) | 2003-10-25 |
| AU2003248355A1 (en) | 2003-09-09 |
| GT200300044A (es) | 2003-09-22 |
| WO2003072571A1 (fr) | 2003-09-04 |
| TW200305414A (en) | 2003-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1110922T1 (el) | Ανταγωνιστες υποδοχεα γλυκαγονης, παρασκευη και θεραπευτικες χρησεις | |
| ECSP077421A (es) | Compuestos y composiciones como inhibidores de la actividad del receptor canabinoide 1 | |
| EA201100062A1 (ru) | Соединения и способы модулирования рецепторов, связанных с белком g | |
| BRPI0408247A (pt) | usos de antagonistas e agonistas de il-23 e reagentes relacionados | |
| CL2012002497A1 (es) | Compuestos derivados de imidazopirimidina,sustituidos, inhibidores de la pde10a; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento o prevencion de trastornos psicoticos, esquizofrenia, enfermedad de parkinson, esclerosis multiple, entre otras. | |
| ATE469897T1 (de) | Indazolcarbonsäureamidverbindungen | |
| ES2337596T3 (es) | Antagonistas del receptor de glucacion, preparacion y usos terapeuticaos. | |
| CL2008002793A1 (es) | Compuestos derivados de amidas sustituidas, inhibidores de la actividad de btk; composicion farmaceutica que los comprende; utiles en el tratamiento del cancer, trastornos oseos, enfermedades autoinmunes, entre otras | |
| WO2005121065A3 (fr) | Agonistes des recepteurs $g(b)2-adrenergiques diaminiques | |
| NO20074567L (no) | Glucagonreseptorantagoniser, fremstilling og terapeutisk anvendelse | |
| EA200900345A1 (ru) | Замещенные ациланилиды и способы их применения | |
| NI201000193A (es) | Formulaciones orales de análogos de citidina y métodos de uso de las mismas. | |
| EA200801551A1 (ru) | Применение сульфонамидных производных в лечении расстройств метаболизма и нервной системы | |
| CY1113159T1 (el) | Ανταγωνιστες υποδοχεα γλυκαγονης, παρασκευη και θεραπευτικες χρησεις | |
| ECSP067021A (es) | Compuestos y composiciones como moduladores del receptor activado por proliferador de peroxisoma (ppar) | |
| NO20056132L (no) | Krystallinsk form av beta2 adrenergisk receptoragonist | |
| BRPI0608012A2 (pt) | método de tratamento de cáncer, método de aumento de atividade de célula nk, método de aumento de resposta ou atividade th1 inata, método de tratamento de uma disfunção mediada por th2, método de tratamento de uma doença imune, usos de uma molécula antagonista e uso de uma molécula agonista | |
| BRPI0510808A (pt) | derivados de benzonitrila para tratar fragilidade musculoesquelética | |
| CU20200012A7 (es) | Composiciones de aminoácidos para el tratamiento de enfermedad hepática | |
| WO2005030678A3 (fr) | Agonistes ethylamino aminosubstitues du recepteur ?eta2-adrenergique | |
| DK1951659T3 (da) | Glucagonreceptorantagonister, fremstilling og terapeutisk anvendelse heraf | |
| MX2022002056A (es) | Compuestos para el tratamiento de enfermedad respiratoria bovina o porcina. | |
| TN2017000026A1 (en) | Substituted bicyclic compounds | |
| CL2011001258A1 (es) | Sales de adicion de acido citrico de (r)-5-((e)-2-pirrolidin-3-il vinil)pirimidina; formas polimorficas monocitrato; composicion farmaceutica que las comprende; y su uso en la prevencion o en el tratamiento del dolor, inflamacion o un trastorno del sistema nervioso central. | |
| PE20211387A1 (es) | Compuestos organicos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20150126 |